Article

Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults

2023-06-12

Abstract excerpt

<h4>Background</h4> T cell immunity is key for the control of viral infections including SARS-CoV-2, in particular with regard to immune memory and protection against arising genetic variants. <h4>Method</h4> We recently evaluated a peptide-based SARS-CoV-2 T cell activator termed CoVac-1 in a first-in-human clinical trial and observed a favorable safety profile and induction of poly-specific T cell responses unti...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0f43ca92-eca2-5ccc-98c0-f5f67bffedb7
DOI: 10.1101/2023.06.07.23291074

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adultsDOI 10.1101/2023.06.07.23291074Read

Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adultsSemantic proximity Read

Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiencySemantic proximity Read

Phase I Trial of a Multi-Peptide COVID-19 Vaccine for the Induction of SARS-CoV-2 T-Cell ImmunitySemantic proximity Read

Tissue-resident memory CD8 T-cell responses elicited by a single injection of a multi-target COVID-19 vaccineSemantic proximity Read

SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19Semantic proximity Read

Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validationSemantic proximity Read

SARS-CoV-2-specific CD8+ T cells from people with long COVID establish and maintain effector phenotype and key TCR signatures over 2 years.Semantic proximity Read

Negligible impact of SARS-CoV-2 variants on CD4 <sup>+</sup> and CD8 <sup>+</sup> T cell reactivity in COVID-19 exposed donors and vaccineesSemantic proximity Read

mRNA COVID-19 vaccine elicits potent adaptive immune response without the acute inflammation of SARS-CoV-2 infectionSemantic proximity Read

COVID-19 Patients Form Memory CD8+ T Cells that Recognize a Small Set of Shared Immunodominant Epitopes in SARS-CoV-2Semantic proximity Read

Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19Semantic proximity Read

T Cell Responses to SARS-CoV-2Semantic proximity Read